Clinical Trials

Lung Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 18 of 18 Clinical Trials Related to Lung Cancer

Clinical Research Trial

S1900A

A Phase II Study of Rucaparib in Patients with Genomic LOH High And/Or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

S1800A

A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

MSK 18-486

A Phase II Randomized Study Assessing the Efficacy of Stereotactic Body Radiotherapy (SBRT) in Patients with Oligometastatic Solid Tumors

Doctor(s) Running This Study
Alyson F. McIntosh, MD, MPHIL
Clinical Research Trial

LungMAP

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

LU-005

A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab (NRG-LU005)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

MSK 19-218 Lung Cancer

Durvalumab with Thoracic Radiation Therapy Without Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (DART)

Doctor(s) Running This Study
Brian J. Patson, MD
Clinical Research Trial

G040241 Lung Cancer

A PHASE III, DOUBLE-BLINDED, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT TREATMENT WITH ATEZOLIZUMAB OR PLACEBO IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH RESECTABLE STAGE II

Doctor(s) Running This Study
Brian J. Patson, MD